$COSM
Cosmos Health Inc. Stock $cosm

$cosm Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000147793224004545 Filed on August 05, 2024

Income Statement

Concept	2024 Q3	2023 Q4	2023
Revenue	$12.41M	$15.84M	$53.38M
YoY Change	-3.22%	31.44%	6.02%
Cost Of Revenue	$11.20M	$14.61M	$49.03M
YoY Change	-3.49%	25.77%	10.45%
Gross Profit	$1.207M	$1.231M	$4.350M
YoY Change	-0.65%	182.8%	-26.98%
Gross Profit Margin	9.72%	7.77%	8.15%
Selling, General & Admin	$1.825M	$14.68M	$20.85M
YoY Change	-33.18%	86.35%	92.79%
% of Gross Profit	151.2%	1192.73%	479.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$89.69K	$135.9K	$353.0K
YoY Change	-28.19%	-179.84%	242.12%
% of Gross Profit	7.43%	11.04%	8.12%
Operating Expenses	$3.447M	$14.82M	$26.18M
YoY Change	-18.56%	91.61%	94.93%
Operating Profit	-$2.240M	-$13.59M	-$21.83M
YoY Change	-25.77%	86.17%	192.09%
Interest Expense	$181.4K	$79.87K	$866.5K
YoY Change	19.93%	-109.33%	-63.06%
% of Operating Profit
Other Income/Expense, Net	$57.33K	-$51.54K	$3.289M
YoY Change	-114.41%	-97.82%	-158.92%
Pretax Income	-$2.183M	-$13.75M	-$18.54M
YoY Change	-36.09%	30.75%	42.03%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.183M	-$20.98M	-$18.54M
YoY Change	-34.83%	-44.94%	34.07%
Net Earnings / Revenue	-17.59%	-132.44%	-34.74%
Basic Earnings Per Share	-$0.45		-$2.15
Diluted Earnings Per Share	-$0.45	-$1.52	-$2.15
COMMON SHARES
Basic Shares Outstanding	17.61M shares	13.40M shares	11.97M shares
Diluted Shares Outstanding	18.42M shares

Balance Sheet

Concept	2024 Q3	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.338M	$3.853M	$3.853M
YoY Change	40.35%	-81.44%	-81.44%
Cash & Equivalents	$3.315M	$3.833M	$3.833M
Short-Term Investments	$22.81K	$20.08K	$20.08K
Other Short-Term Assets	$8.309M	$6.253M	$6.253M
YoY Change	-4.89%	15.13%	15.13%
Inventory	$4.885M	$4.789M	$4.789M
Prepaid Expenses
Receivables	$17.48M	$19.76M	$20.86M
Other Receivables	$937.7K	$854.3K	$854.3K
Total Short-Term Assets	$36.24M	$36.61M	$36.61M
YoY Change	-22.04%	-34.68%	-34.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.58M	$10.46M	$11.62M
YoY Change	3.18%	475.42%	296.46%
Goodwill	$49.70K	$49.70K
YoY Change	0.0%	0.0%
Intangibles	$7.697M	$7.634M
YoY Change	91.67%	1061.64%
Long-Term Investments
YoY Change
Other Assets	$2.765M	$3.058M	$3.058M
YoY Change	6.35%	328.51%	328.51%
Total Long-Term Assets	$28.28M	$29.41M	$29.41M
YoY Change	12.95%	145.19%	145.19%
TOTAL ASSETS
Total Short-Term Assets	$36.24M	$36.61M	$36.61M
Total Long-Term Assets	$28.28M	$29.41M	$29.41M
Total Assets	$64.52M	$66.01M	$66.01M
YoY Change	-9.79%	-2.97%	-2.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.63M	$12.14M	$12.14M
YoY Change	-0.87%	0.16%	0.16%
Accrued Expenses	$185.6K	$166.3K	$451.9K
YoY Change	124.92%	-39.63%	2.03%
Deferred Revenue
YoY Change
Short-Term Debt	$6.022M	$6.655M	$6.655M
YoY Change	11.97%	13.13%	13.13%
Long-Term Debt Due	$1.641M	$1.598M	$1.598M
YoY Change	38.13%	-29.15%	-29.15%
Total Short-Term Liabilities	$25.21M	$24.32M	$24.32M
YoY Change	11.63%	11.83%	11.83%
LONG-TERM LIABILITIES
Long-Term Debt	$2.651M	$1.327M	$3.041M
YoY Change	-22.53%	-56.7%	-0.83%
Other Long-Term Liabilities	$1.213M	$1.764M	$2.609M
YoY Change	277.31%	29.81%	-26.87%
Total Long-Term Liabilities	$1.213M	$1.764M	$5.649M
YoY Change	277.31%	29.81%	-14.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.21M	$24.32M	$24.32M
Total Long-Term Liabilities	$1.213M	$1.764M	$5.649M
Total Liabilities	$29.54M	$29.97M	$29.97M
YoY Change	9.59%	5.6%	5.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$104.5M	-$91.64M
YoY Change	47.07%	38.37%
Common Stock	$23.35K	$15.98K
YoY Change	78.64%	50.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$917.2K
YoY Change		12.3%
Treasury Stock Shares
Shareholders Equity	$34.98M	$36.04M	$36.04M
YoY Change
Total Liabilities & Shareholders Equity	$64.52M	$66.01M	$66.01M
YoY Change	-9.79%	-2.97%	-2.97%

Cashflow Statement

Concept	2024 Q3	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.183M	-$20.98M	-$18.54M
YoY Change	-34.83%	-44.94%	34.07%
Depreciation, Depletion And Amortization	$89.69K	$135.9K	$353.0K
YoY Change	-28.19%	-179.84%	242.12%
Cash From Operating Activities	$739.8K	$951.7K	-$15.64M
YoY Change	-116.34%	-109.22%	5.15%
INVESTING ACTIVITIES
Capital Expenditures	$228.8K	$3.558M	$1.313M
YoY Change	-52.8%	10343.5%	1669.64%
Acquisitions
YoY Change
Other Investing Activities	$193.3K	$197.0K	-$6.258M
YoY Change	-113.11%	141.67%	-1830.63%
Cash From Investing Activities	-$35.43K	-$3.361M	-$13.76M
YoY Change	-98.18%	-7186.44%	63910.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$100.5K
YoY Change			-99.72%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.680M	4.292M	$12.69M
YoY Change	-57.74%	-85.96%	-63.78%
NET CHANGE
Cash From Operating Activities	739.8K	951.7K	-$15.64M
Cash From Investing Activities	-35.43K	-3.361M	-$13.76M
Cash From Financing Activities	2.680M	4.292M	$12.69M
Net Change In Cash	3.384M	1.883M	-$16.92M
YoY Change	-2602.48%	-90.72%	-182.67%
FREE CASH FLOW
Cash From Operating Activities	$739.8K	$951.7K	-$15.64M
Capital Expenditures	$228.8K	$3.558M	$1.313M
Free Cash Flow	$511.0K	-$2.606M	-$16.95M
YoY Change	-110.19%	-74.82%	13.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001474167
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Trading Symbol TradingSymbol	COSM
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Preferred Units Authorized PreferredUnitsAuthorized	100	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	62619	usd
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	460728	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	525000	usd
CY2022	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	306637	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-54436
CY2023	dei	Entity Registrant Name EntityRegistrantName	COSMOS HEALTH INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-0611758
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Agiou Georgiou Str
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Pilea
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Thessaloniki
CY2023	dei	Entity Address Country EntityAddressCountry	GR
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55438
CY2023	dei	City Area Code CityAreaCode	312
CY2023	dei	Local Phone Number LocalPhoneNumber	536-3102
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	28804620	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17606312	shares
CY2023	dei	Auditor Name AuditorName	RBSM LLP
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023	dei	Auditor Firm AuditorFirmId	587
CY2023Q4	cosm	Loans Receivable Current LoansReceivableCurrent	411858	usd
CY2022Q4	cosm	Loans Receivable Current LoansReceivableCurrent	377038	usd
CY2023Q4	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	4440855	usd
CY2022Q4	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	3397000	usd
CY2023Q4	cosm	Loans Receivable Related Party Long Term LoansReceivableRelatedPartyLongTerm	3539840	usd
CY2022Q4	cosm	Loans Receivable Related Party Long Term LoansReceivableRelatedPartyLongTerm	3851280	usd
CY2023Q4	cosm	Convertible Notes Payable Net Of Unamortized Discount ConvertibleNotesPayableNetOfUnamortizedDiscount	0	usd
CY2022Q4	cosm	Convertible Notes Payable Net Of Unamortized Discount ConvertibleNotesPayableNetOfUnamortizedDiscount	258938	usd
CY2023Q4	cosm	Convertible Notes Payable Unamortized Discount ConvertibleNotesPayableUnamortizedDiscount	0	usd
CY2022Q4	cosm	Convertible Notes Payable Unamortized Discount ConvertibleNotesPayableUnamortizedDiscount	100000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	54293	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	126855	usd
CY2023Q4	cosm	Share Settled Debt Obligation ShareSettledDebtObligation	0	usd
CY2022Q4	cosm	Share Settled Debt Obligation ShareSettledDebtObligation	1554590	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	372414	usd
CY2023Q4	us-gaap	Treasury Stock Preferred Shares TreasuryStockPreferredShares	86497	shares
CY2022Q4	us-gaap	Treasury Stock Preferred Shares TreasuryStockPreferredShares	15497	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	917159	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	816707	usd
CY2023	us-gaap	Revenues Revenues	53376874	usd
CY2022	us-gaap	Revenues Revenues	50347652	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	49027305	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	44390695	usd
CY2023	us-gaap	Gross Profit GrossProfit	4349569	usd
CY2022	us-gaap	Gross Profit GrossProfit	5956957	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19642005	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10183025	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	4719768	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	2429021	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1204636	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	630057	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	614377	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	188890	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	26180786	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	13430993	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-21831217	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-7474036	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-65867	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2424649	usd
CY2023	us-gaap	Interest Expense InterestExpense	866476	usd
CY2022	us-gaap	Interest Expense InterestExpense	2345410	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	662859	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	236349	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	1619838	usd
CY2023	cosm	Gain Loss On Sales Of Equity Investments GainLossOnSalesOfEquityInvestments	4584	usd
CY2022	cosm	Gain Loss On Sales Of Equity Investments GainLossOnSalesOfEquityInvestments	1676	usd
CY2023	cosm	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	1910967	usd
CY2022	cosm	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	1004124	usd
CY2023	cosm	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	3384	usd
CY2022	cosm	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-20257	usd
CY2023	cosm	Bargain Purchase Gain BargainPurchaseGain	1440249	usd
CY2022	cosm	Bargain Purchase Gain BargainPurchaseGain	0	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	198863	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-413279	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3288563	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5581284	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18542654	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13055320	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-775051	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18542654	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13830371	usd
CY2022	cosm	Deemed Dividend On Issuance Of Warrants DeemedDividendOnIssuanceOfWarrants	-32004730	usd
CY2023	cosm	Deemed Dividend On Downround Of Warrants DeemedDividendOnDownroundOfWarrants	-22695	usd
CY2022	cosm	Deemed Dividend On Downround Of Warrants DeemedDividendOnDownroundOfWarrants	-8480379	usd
CY2023	cosm	Deemed Dividend On Warrant Exchange DeemedDividendOnWarrantExchange	-7218485	usd
CY2022	cosm	Deemed Dividend On Warrant Exchange DeemedDividendOnWarrantExchange	-1067876	usd
CY2022	cosm	Deemed Dividend On Downround Of Preferred Stock DeemedDividendOnDownroundOfPreferredStock	-8189515	usd
CY2022	cosm	Deemed Dividend On Preferred Stock DeemedDividendOnPreferredStock	-372414	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25783834	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-63945285	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	712791	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-981014	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25071043	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-64926299	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.15
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-33.16
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.15
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-33.16
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	11968665	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	1928172	shares
CY2023	us-gaap	Weighted Average Limited Partnership Units Outstanding Diluted WeightedAverageLimitedPartnershipUnitsOutstandingDiluted	11968665	shares
CY2022	us-gaap	Weighted Average Limited Partnership Units Outstanding Diluted WeightedAverageLimitedPartnershipUnitsOutstandingDiluted	1928172	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4379463	usd
CY2022	cosm	Foreign Currency Translation Adjustment Net ForeignCurrencyTranslationAdjustmentNet	-981014	usd
CY2022	cosm	Adoption Of Asus AdoptionOfAsus	-240752	usd
CY2022	cosm	Issuance Of Series A Preferred Stock Amount IssuanceOfSeriesAPreferredStockAmount	0	usd
CY2022	cosm	Conversion Of Series A Preferred Stock Amount ConversionOfSeriesAPreferredStockAmount	5452300	usd
CY2022	cosm	Sale Of Common Stock Amount SaleOfCommonStockAmount	6622924	usd
CY2022	cosm	Sale Of Warrants Bundled With Common Stock SaleOfWarrantsBundledWithCommonStock	26216237	usd
CY2022	cosm	Exercise Of Warrants Amount ExerciseOfWarrantsAmount	10826000	usd
CY2022	cosm	Conversion Of Notes Payable Into Shares Of Common Stock Amount ConversionOfNotesPayableIntoSharesOfCommonStockAmount	973420	usd
CY2022	cosm	Conversion Of Convertible Debt Amount ConversionOfConvertibleDebtAmount	38144	usd
CY2022	cosm	Cashless Exercise Of Warrants Amount CashlessExerciseOfWarrantsAmount	0	usd
CY2022	cosm	Shares Issued In Lieu Of Cash Amount SharesIssuedInLieuOfCashAmount	175941	usd
CY2022	cosm	Fair Value Of Warrants Issued In Lieu Of Cash FairValueOfWarrantsIssuedInLieuOfCash	24401	usd
CY2022	cosm	Deemed Dividend Upon Downround Of Preferred Stock And DeemedDividendUponDownroundOfPreferredStockAnd	0	usd
CY2022	cosm	Deemed Dividend On Preferred Stock DeemedDividendOnPreferredStock	-372414	usd
CY2022	cosm	Deemed Dividend On Warrant Exchange Amount DeemedDividendOnWarrantExchangeAmount	0	usd
CY2022	cosm	Rounding Upon Reverse Stock Split Of1 For25 Common Shares Amount RoundingUponReverseStockSplitOf1For25CommonSharesAmount	16	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13830371	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	39284295	usd
CY2023	cosm	Foreign Currency Translation Adjustment Net ForeignCurrencyTranslationAdjustmentNet	712791	usd
CY2023	cosm	Proceeds From Sale Of Common Stock ProceedsFromSaleOfCommonStock	4750088	usd
CY2023	cosm	Proceeds From Sale Of Common Stock Net Of Financing Fees Of Amount ProceedsFromSaleOfCommonStockNetOfFinancingFeesOfAmount	4807038	usd
CY2023	cosm	Proceed From Exercise Warrants Amount ProceedFromExerciseWarrantsAmount	3258741	usd
CY2023	cosm	Shares Issued In Lieu Of Cash Amount SharesIssuedInLieuOfCashAmount	96888	usd
CY2023	cosm	Shares Issued For Purchase Of Customer Base Amount SharesIssuedForPurchaseOfCustomerBaseAmount	316081	usd
CY2023	cosm	Shares Issued For Purchase Of Cana Amount SharesIssuedForPurchaseOfCanaAmount	138667	usd
CY2023	cosm	Shares Issued For Purchase Of Cloudscreen Amount SharesIssuedForPurchaseOfCloudscreenAmount	319200	usd
CY2023	cosm	Shares Issued Upon Exchange Of Related Party Debt Amount SharesIssuedUponExchangeOfRelatedPartyDebtAmount	52000	usd
CY2023	cosm	Stock Based Compensation Amount StockBasedCompensationAmount	577931	usd
CY2023	cosm	Repurchase Of Treasury Stock Amount RepurchaseOfTreasuryStockAmount	-100452	usd
CY2023	cosm	Deemed Dividend Reclassified Upon Elimination Of Its Redemption Provision DeemedDividendReclassifiedUponEliminationOfItsRedemptionProvision	372414	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18542654	usd
CY2023	cosm	Deemed Dividend Upon Issunace And Downround Of Warrants DeemedDividendUponIssunaceAndDownroundOfWarrants	0	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	36043028	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-18542654	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-13830371	usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	590691	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	103194	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	23686	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	85696	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1619838	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11850788	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5621938	usd
CY2023	cosm	Provisions For Extraordinary Tax Charges ProvisionsForExtraordinaryTaxCharges	-578425	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2023	cosm	Shares Issued In Lieu Of Cash SharesIssuedInLieuOfCash	-96888	usd
CY2022	cosm	Shares Issued In Lieu Of Cash SharesIssuedInLieuOfCash	-175941	usd
CY2023	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	365639	usd
CY2022	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	210463	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2903	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	16467	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	577931	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	24401	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	78553	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	780099	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1910967	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	876894	usd
CY2023	cosm	Gain Loss On Bargain Purchase GainLossOnBargainPurchase	1440249	usd
CY2022	cosm	Cash Paid For The Acquisition Of Cana CashPaidForTheAcquisitionOfCana	0	usd
CY2023	cosm	Change In Fair Value Of The Derivative Liability ChangeInFairValueOfTheDerivativeLiability	3384	usd
CY2022	cosm	Change In Fair Value Of The Derivative Liability ChangeInFairValueOfTheDerivativeLiability	-20257	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	4584	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	1676	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	127230	usd
CY2023	us-gaap	Other Income OtherIncome	928	usd
CY2023	cosm	Sale Of Fixed Assets SaleOfFixedAssets	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5484213	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3073366	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-1457845	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	170815	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	890903	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	485469	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	579467	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	894893	usd
CY2023	cosm	Increase Decrease In Prepaid Expenses And Other Current Assets Related Party IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssetsRelatedParty	913574	usd
CY2022	cosm	Increase Decrease In Prepaid Expenses And Other Current Assets Related Party IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssetsRelatedParty	375311	usd
CY2022	cosm	Proceeds From Loan Receivable Related Party ProceedsFromLoanReceivableRelatedParty	4213728	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	644838	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2092104	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	71777	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-357681	usd
CY2023	cosm	Increase Decrease In Accrued Interest IncreaseDecreaseInAccruedInterest	-115668	usd
CY2022	cosm	Increase Decrease In Accrued Interest IncreaseDecreaseInAccruedInterest	-913280	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-373816	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-210781	usd
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-128801	usd
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-1107135	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1359180	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-320420	usd
CY2023	cosm	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	-227575	usd
CY2022	cosm	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	1338013	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15635999	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14870639	usd
CY2023	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	806464	usd
CY2022	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	351474	usd
CY2023	cosm	Cash Paid For The Acquisition Of Cana CashPaidForTheAcquisitionOfCana	-5230593	usd
CY2022	cosm	Advances For Buildings Acquisitions AdvancesForBuildingsAcquisitions	0	usd
CY2023	cosm	Loans And Leases Receivable Related Party LoansAndLeasesReceivableRelatedParty	-168469	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2022	cosm	Sale Of Fixed Assets SaleOfFixedAssets	12736	usd
CY2023	cosm	Advances For Buildings Acquisitions AdvancesForBuildingsAcquisitions	-1665000	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6189564	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	308866	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2634	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1313195	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	74207	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13760357	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21497	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	100000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	525000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	421373	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1611774	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	12479735	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1057540	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	487098	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	4824035	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3625007	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	1065000	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	65000	usd
CY2023	cosm	Payment Of Lines Of Credit PaymentOfLinesOfCredit	19532735	usd
CY2022	cosm	Payment Of Lines Of Credit PaymentOfLinesOfCredit	20975110	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	20193343	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	22354567	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6000000	usd
CY2023	cosm	Financing Fees From The Sale Of Common Stock FinancingFeesFromTheSaleOfCommonStock	10000017	usd
CY2022	cosm	Financing Fees From The Sale Of Common Stock FinancingFeesFromTheSaleOfCommonStock	35275573	usd
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3533741	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	10826000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	27786	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	99906	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	717888	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3194798	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	100452	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12694007	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35048288	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-214139	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	307044	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16916488	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	20463196	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20749683	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	286487	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3833195	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20749683	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	406885	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	588051	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	cosm	Common Shares Issued For Acquisition Of Customer Base CommonSharesIssuedForAcquisitionOfCustomerBase	316081	shares
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	cosm	Common Shares Issued For Acquisition Of Cana CommonSharesIssuedForAcquisitionOfCana	138667	shares
CY2023	cosm	Conversion Of Notes Payable To Common Stock ConversionOfNotesPayableToCommonStock	0	usd
CY2022	cosm	Conversion Of Notes Payable To Common Stock ConversionOfNotesPayableToCommonStock	973420	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	372414	usd
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	15000	shares
CY2023	cosm	Deemed Dividend On Warrants Upon Conversion Of Convertible Debt DeemedDividendOnWarrantsUponConversionOfConvertibleDebt	7218485	usd
CY2022	cosm	Deemed Dividend On Warrants Upon Conversion Of Convertible Debt DeemedDividendOnWarrantsUponConversionOfConvertibleDebt	32004730	usd
CY2022	cosm	Deemed Dividend On Preferred Stock And Warrants Upon Trigger Of Downround Feature DeemedDividendOnPreferredStockAndWarrantsUponTriggerOfDownroundFeature	16669894	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	372414	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	5452300	usd
CY2022	cosm	Conversion Of Convertible Debt ConversionOfConvertibleDebt	38144	usd
CY2023	us-gaap	Revenues Revenues	53376874	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-18542654	usd
CY2023	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	14998919	usd
CY2023Q4	cosm	Working Capital WorkingCapital	12285310	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-91644233	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	36043028	usd
CY2023	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	1908195	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p>
CY2023	cosm	Schedule Of Foreign Currency Translation And Other Comprehensive Losstabletextblock ScheduleOfForeignCurrencyTranslationAndOtherComprehensiveLosstabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Exchange rate on balance sheet dates</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">EUR: USD exchange rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.1062</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.0698</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">GBP: USD exchange rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2743</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2077</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Average exchange rate for the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">EUR: USD exchange rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.0817</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.0534</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">GBP: USD exchange rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2440</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2371</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q4	cosm	Foreign Accounts ForeignAccounts	1047738	usd
CY2022Q4	cosm	Foreign Accounts ForeignAccounts	831793	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	48590	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	15690	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain reclassifications have been made in the Company’s financial statements of the prior year to conform with current year presentation. As of December 31, 2022, $421,302, $322,010, $120,294 and $66,401 (an aggregate total of $930,006) was reclassified from “Prepaid expenses and other current assets,” “Other assets,” “Accounts receivable – related party,” and “Prepaid expenses and other current assets – related party,” respectively to “Accounts receivable, net”. Moreover, $248,678 was reclassified from “Financing lease right-of-use asset” to “Operating lease right-of-use asset” and $247,595 was reclassified from Financing Lease Liabilities to Operating Lease Liabilities as of the year ended, December 31, 2022. Finally, an amount of $1,784,751 was reclassified from “Accounts payable and accrued expenses” to “Other current liabilities” as of the year ended, December 31, 2022. These reclassifications had no impact on earnings or stockholders’ equity.</p>
CY2022Q4	cosm	Reclassified From Line Of Credit To Notes Payable ReclassifiedFromLineOfCreditToNotesPayable	930006	usd
CY2022Q4	cosm	Finance Lease Right Of Use Asset Other FinanceLeaseRightOfUseAssetOther	248678	usd
CY2022Q4	cosm	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	247595	usd
CY2022Q4	cosm	Reclassified From Accounts Receivable ReclassifiedFromAccountsReceivable	1784751	usd
CY2023	cosm	Allowance For Doubtful Accounts AllowanceForDoubtfulAccounts	19686091	usd
CY2022	cosm	Allowance For Doubtful Accounts AllowanceForDoubtfulAccounts	7309311	usd
CY2023	cosm	Changes In Allowance For Doubtful Accounts Beginning Balance ChangesInAllowanceForDoubtfulAccountsBeginningBalance	7309311	usd
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	11850788	usd
CY2023	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	0	usd
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	525992	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	0	usd
CY2023	cosm	Changes In Allowance For Doubtful Accounts Ending Balance ChangesInAllowanceForDoubtfulAccountsEndingBalance	19686091	usd
CY2023Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	187512	usd
CY2022Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	79373	usd
CY2023	us-gaap	Depreciation Depreciation	353043	usd
CY2022	us-gaap	Depreciation Depreciation	70109	usd
CY2018Q4	us-gaap	Goodwill Goodwill	49697	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	239841	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33085	usd
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	11596	usd
CY2022Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	6681	usd
CY2023	cosm	Sales To Medihelm SalesToMedihelm	397000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash investments and accounts receivable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company had no clients which contributed 10% or more of revenue and accounts receivable, respectively for the year ended December 31, 2023.</p>
CY2023Q4	cosm	Long Term Liabilities LongTermLiabilities	408665	usd
CY2022Q4	cosm	Long Term Liabilities LongTermLiabilities	0	usd
CY2023	cosm	Payable To Actuarial Expert PayableToActuarialExpert	408665	usd
CY2022	cosm	Payable To Actuarial Expert PayableToActuarialExpert	147776	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11968665	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1928172	shares
CY2023	cosm	Weighted Average Number Of Common And Equivalent Shares Outstanding Diluted WeightedAverageNumberOfCommonAndEquivalentSharesOutstandingDiluted	11968665	shares
CY2022	cosm	Weighted Average Number Of Common And Equivalent Shares Outstanding Diluted WeightedAverageNumberOfCommonAndEquivalentSharesOutstandingDiluted	1928172	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	8561476	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	4194236	shares
CY2022	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	8827	shares
CY2023	cosm	Potential Common Shares PotentialCommonShares	8561476	shares
CY2022	cosm	Potential Common Shares PotentialCommonShares	4203063	shares
CY2021Q4	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	4849221	usd
CY2021Q4	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.055	pure
CY2021Q4	cosm	Threshold Period Past Due For Writeoffs Of Financing Receivable ThresholdPeriodPastDueForWriteoffsOfFinancingReceivable	P360Y
CY2021Q4	cosm	Decription Of Loan Payment DecriptionOfLoanPayment	the Company is to receive 120 equal payments over the term of the loan
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	377038	usd
CY2022Q4	us-gaap	Nontrade Receivables NontradeReceivables	3792034	usd
CY2023	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	389867	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	411858	usd
CY2023Q4	us-gaap	Nontrade Receivables NontradeReceivables	3509200	usd
CY2023	cosm	Interest Payments InterestPayments	193265	usd
CY2023Q4	us-gaap	Preferred Units Authorized PreferredUnitsAuthorized	100000000	shares
CY2022Q2	cosm	Liquidated Damages Payable LiquidatedDamagesPayable	250260	usd
CY2022Q2	cosm	Description Of Late Filing Of Registration Statement DescriptionOfLateFilingOfRegistrationStatement	the 1st anniversary (30 days following the event date) of the event, which, along with an additional lump sum amount of $2,000,000 agreed to be paid to the investors as additional damages, led to a total amount of $2,250,260 concerning liquidated damages related to the February Private Placement within the year ended December 31, 2022
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	15.54
CY2022Q2	us-gaap	Investment Income Dividend InvestmentIncomeDividend	8189515	usd
CY2022Q2	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	from $75.00 to $15.54
CY2023Q4	cosm	Series A Preferred Stock SeriesAPreferredStock	5452300	usd
CY2022	cosm	Convertible Stock ConvertibleStock	6000	shares
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	386588	shares
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	5452300	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15982472	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10605412	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15895975	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10589915	shares
CY2022	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	300	shares
CY2022	cosm	Compensation Expense For Services Rendered CompensationExpenseForServicesRendered	3120	usd
CY2022Q4	cosm	Description Of Reverse Split DescriptionOfReverseSplit	the Company announced a reverse stock split with a ratio of 1-for-25 (one-for-twenty five) effective at the opening of the business day on Friday, December 16, 2022. The CUSIP number of the Company after the split will change to 221413-305. The reverse stock split was authorized at the Company’s Annual General Meeting (“AGM”) on December 2, 2022 and was approved by the Company’s Board of Directors on December 15, 2022
CY2022	cosm	Issued Shares Of Common Stock Upon The Exercise IssuedSharesOfCommonStockUponTheExercise	3608667	shares
CY2022	cosm	Gross Proceeds Upon The Exercise Of Warrants GrossProceedsUponTheExerciseOfWarrants	10826000	usd
CY2022	cosm	Issued Shares Of Common Stock Upon The Cashless Exercise IssuedSharesOfCommonStockUponTheCashlessExercise	526112	shares
CY2022	cosm	Cashless Exercise Warrants CashlessExerciseWarrants	776674	shares
CY2023	cosm	Issued Shares Of Common Stock Upon The Exercise IssuedSharesOfCommonStockUponTheExercise	2437063	shares
CY2023	cosm	Gross Proceeds Upon The Exercise Of Warrants GrossProceedsUponTheExerciseOfWarrants	3533741	usd
CY2023	us-gaap	Provision For Other Losses ProvisionForOtherLosses	-18542654	usd
CY2022	us-gaap	Provision For Other Losses ProvisionForOtherLosses	-13055320	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-75724	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-75724	usd
CY2023	cosm	Deferred Domestic Income Tax Expense Benefit DeferredDomesticIncomeTaxExpenseBenefit	0	usd
CY2022	cosm	Deferred Domestic Income Tax Expense Benefit DeferredDomesticIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	850775	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	850775	usd
CY2023	cosm	Total Current Provision TotalCurrentProvision	0	usd
CY2022	cosm	Total Current Provision TotalCurrentProvision	775051	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-18542654	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-13055320	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3893957	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2741617	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4339572	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3989786	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	245518	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	34601	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-448032	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	128705	usd
CY2023	cosm	Prior Period Adjustments PriorPeriodAdjustments	-151879	usd
CY2022	cosm	Prior Period Adjustments PriorPeriodAdjustments	-186143	usd
CY2023	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-91222	usd
CY2022	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-450280	usd
CY2023	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	0	usd
CY2022	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	775052	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	21516941	usd
CY2023	cosm	Federal Statutory Income Tax Rate Description FederalStatutoryIncomeTaxRateDescription	the $21.5 million Federal NOL carryforwards, $2.5 million are pre-2018 and begin to expire in 2031. The remaining balance of $19 million, are limited to utilization of 80% of taxable income but do not have an expiration
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	6630273	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	5758737	usd
CY2023Q4	cosm	Beginning Balance Convertible Notes BeginningBalanceConvertibleNotes	100000	usd
CY2022Q4	cosm	Beginning Balance Convertible Notes BeginningBalanceConvertibleNotes	640000	usd
CY2022Q4	cosm	New Notes NewNotes	0	usd
CY2023Q4	cosm	Payments To Convertible Debt PaymentsToConvertibleDebt	-100000	usd
CY2022Q4	cosm	Payments To Convertible Debt PaymentsToConvertibleDebt	-525000	usd
CY2022Q4	cosm	Conversion To Common Stock ConversionToCommonStock	-15000	usd
CY2023Q4	cosm	Subtotal Notes To Convertible Debt SubtotalNotesToConvertibleDebt	0	usd
CY2022Q4	cosm	Subtotal Notes To Convertible Debt SubtotalNotesToConvertibleDebt	100000	usd
CY2023Q4	cosm	Accretions Amortization Of Discounts And Premiums Investments AccretionsAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2022Q4	cosm	Accretions Amortization Of Discounts And Premiums Investments AccretionsAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	100000	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	11629	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	100000	usd
CY2023Q4	cosm	Accrued Interest Expense AccruedInterestExpense	13740	usd
CY2023	cosm	Gain On Settlement Of Debt GainOnSettlementOfDebt	50909	usd
CY2023Q4	cosm	Convertible Note Payable Net ConvertibleNotePayableNet	525000	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	45665	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	cosm	Reduction Of Derivative Related To Conversions ReductionOfDerivativeRelatedToConversions	11629	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	20257	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	54293	usd
CY2023	cosm	Reduction Of Derivative Related To Conversions ReductionOfDerivativeRelatedToConversions	50909	usd
CY2023	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-3384	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	cosm	Beginning Balance Loans BeginningBalanceLoans	5017987	usd
CY2023	cosm	Proceed From Debt ProceedFromDebt	1082231	usd
CY2023	cosm	Payments Of Debt PaymentsOfDebt	-1597894	usd
CY2023	cosm	Oher Additions Of Debt OherAdditionsOfDebt	317880	usd
CY2023	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	306637	usd
CY2023	cosm	Foreign Currency Translation ForeignCurrencyTranslation	92660	usd
CY2023Q4	cosm	Subtotal Of Debts SubtotalOfDebts	4606227	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	3035341	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	1570886	usd
CY2022	cosm	Beginning Balance Loans BeginningBalanceLoans	18226062	usd
CY2022	cosm	Proceed From Debt ProceedFromDebt	492336	usd
CY2022	cosm	Payments Of Debt PaymentsOfDebt	-12541343	usd
CY2022	cosm	Conversion Of Debt ConversionOfDebt	-1190000	usd
CY2022	cosm	Recapitalized Upon Debt Modification RecapitalizedUponDebtModification	-1084735	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1079844	usd
CY2022	cosm	Reclassification Of Line Of Credit ReclassificationOfLineOfCredit	0	usd
CY2022	cosm	Foreign Currency Translation ForeignCurrencyTranslation	35823	usd
CY2022Q4	cosm	Subtotal Of Debts SubtotalOfDebts	5017987	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2859570	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	2158417	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1570886	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2032967	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	457784	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	312314	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	232276	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	4606227	usd
CY2023Q4	cosm	Less Notes Payable Current Portion LessNotesPayableCurrentPortion	-1570886	usd
CY2023Q4	cosm	Notes Payable Long Term Portion NotesPayableLongTermPortion	3035341	usd
CY2023	cosm	Trade Finance Facility Agreement Interest Rate Description TradeFinanceFacilityAgreementInterestRateDescription	one-month Euribor (3.90% as of December 31, 2023), and 6% plus one-month LIBOR (fully paid as of December 31, 2023), respectively
CY2023	cosm	Final Repayment Shares FinalRepaymentShares	1965600	shares
CY2023	cosm	Repayment Of Installment RepaymentOfInstallment	500000	usd
CY2022Q1	us-gaap	Debt Current DebtCurrent	3950000	usd
CY2022Q1	cosm	Capitalized Fees CapitalizedFees	221060	usd
CY2023	cosm	Non Cash Interest Expenses NonCashInterestExpenses	200000	usd
CY2022	cosm	Total Repayments Of Debt TotalRepaymentsOfDebt	191100	usd
CY2022Q4	us-gaap	Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid	2593363	usd
CY2022Q4	cosm	Loan Amount Principal LoanAmountPrincipal	1898895	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4878	usd
CY2021Q3	us-gaap	Debt Current DebtCurrent	578850	usd
CY2023	cosm	Stock Issued For Debt Obligation StockIssuedForDebtObligation	420471	shares
CY2023	cosm	Operating Lease Term Of Agreements OperatingLeaseTermOfAgreements	The Company has various operating and finance lease agreements with terms up to ten years, for various types of property and equipment (such as office space and vehicles) etc. Some leases include options to purchase, terminate or extend for one or more years. These options are included in the lease term when it is reasonably certain that the option will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y7M28D
CY2023	cosm	Operating Lease Weighted Average Discount Rate OperatingLeaseWeightedAverageDiscountRate	0.0674	pure
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	364968	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	210463	usd
CY2023	us-gaap	Acquired Finite Lived Intangible Asset Weighted Average Period Before Renewal Or Extension AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension	P1Y1M28D
CY2023	cosm	Finance Lease Weighted Average Discount Rate FinanceLeaseWeightedAverageDiscountRate	0.0674	pure
CY2023	cosm	Operating Lease Cash Flows Used In Finance Lease OperatingLeaseCashFlowsUsedInFinanceLease	28420	usd
CY2022	cosm	Operating Lease Cash Flows Used In Finance Lease OperatingLeaseCashFlowsUsedInFinanceLease	99906	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2903	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	16467	usd
CY2023	cosm	Finance Lease Amortization Expense FinanceLeaseAmortizationExpense	23685	usd
CY2022	cosm	Finance Lease Amortization Expense FinanceLeaseAmortizationExpense	85696	usd
CY2023	cosm	Tax Liabilities Payable TaxLiabilitiesPayable	2430517	usd
CY2023	cosm	Payroll Tax Related Current Liabilities PayrollTaxRelatedCurrentLiabilities	1046507	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	591547	usd
CY2023	cosm	Provision For Staff Leaving Compensation ProvisionForStaffLeavingCompensation	408665	usd
CY2023	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	207204	usd
CY2023	cosm	Compensation For Non Pecuniary Damage Amounting CompensationForNonPecuniaryDamageAmounting	21744	usd
CY2023	cosm	Payment Tax PaymentTax	99644	usd
CY2021Q3	cosm	Advisory Description AdvisoryDescription	the Company paid $100,000. The $100,000 bonus was incurred and settled within 2022. Finally, the Consultant received a total of 10,000 shares of the Company’s common stock, 2,000 of such shares that have been previously issued pursuant to previous agreements and additional 15,258 shares that were issued on February 2, 2023, based on the amendment signed on February 1, 2023
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	164859	usd
CY2023	cosm	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-25783834	usd
CY2022	cosm	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-63945285	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11968665	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1928172	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11968665	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1928172	shares
CY2023	cosm	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-2.15
CY2022	cosm	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-33.16
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8561476	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4203063	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2023	cosm	Discription Of Incentive Stock Awards DiscriptionOfIncentiveStockAwards	The awards are in the form of restricted stock and will vest in two parts: 50% on October 2, 2023 and 50% on October 2, 2024
CY2023Q2	cosm	Awarded Shares AwardedShares	185000	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	323957	usd
CY2023	us-gaap	Revenues Revenues	53376874	usd
CY2022	us-gaap	Revenues Revenues	50347652	usd
CY2023	us-gaap	Revenues Revenues	53376874	usd
CY2023	cosm	Segment Reporting Profit Loss SegmentReportingProfitLoss	-9439727	usd
CY2023Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	75724599	usd

Files In Submission

Name	View Source	Status
0001477932-24-004545-index-headers.html	Edgar Link	pending
0001477932-24-004545-index.html	Edgar Link	pending
0001477932-24-004545.txt	Edgar Link	pending
0001477932-24-004545-xbrl.zip	Edgar Link	pending
cosm-20231231.xsd	Edgar Link	pending
cosm_10k.htm	Edgar Link	pending
cosm_10kimg6.jpg	Edgar Link	pending
cosm_10kimg8.jpg	Edgar Link	pending
cosm_ex21.htm	Edgar Link	pending
cosm_ex231.htm	Edgar Link	pending
cosm_ex231img2.jpg	Edgar Link	pending
cosm_ex232.htm	Edgar Link	pending
cosm_ex311.htm	Edgar Link	pending
cosm_ex312.htm	Edgar Link	pending
cosm-20231231_pre.xml	Edgar Link	unprocessable
cosm_10k_htm.xml	Edgar Link	completed
cosm_ex321.htm	Edgar Link	pending
cosm_ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cosm-20231231_cal.xml	Edgar Link	unprocessable
cosm-20231231_lab.xml	Edgar Link	unprocessable
cosm-20231231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COSM
Cosmos Health Inc. Stock $cosm

2024 Q3 Form 10-K Financial Statement

#000147793224004545 Filed on August 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COSM Cosmos Health Inc. Stock $cosm

2024 Q3 Form 10-K Financial Statement

#000147793224004545 Filed on August 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COSM
Cosmos Health Inc. Stock $cosm